Clinical trial
PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by…
NCT00002930 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00002930 |
|---|---|
| Title | PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery |
| Official title | Whole-Body 18F-Fluorodeoxyglucose Positron Emission Tomography to Measure the Response to Induction Chemotherapy of Potentially Resectable Lung and Esophageal Carcinomas |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Esophageal Cancer, Lung Cancer |
| Intervention type | Procedure, Radiation |
| Interventions | positron emission tomography, fludeoxyglucose F 18 |
| Enrollment | 75 |
| Start date | Dec 1, 1996 |
| Primary completion | Oct 1, 2002 |
| First posted | Mar 12, 2004 |
| Last update posted | Jan 18, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: